UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z
Number of items: 350.

A

Abbott, WGH; Rigópoulou, E; Haigh, P; Cooksley, H; Mullerova, I; Novelli, M; Winstanley, A; ... Naoumov, NV; + view all (2004) Single nucleotide polymorphisms in the interferon-γ and interleukin-10 genes do not influence chronic hepatitis C severity or T-cell reactivity to hepatitis C virus. Liver International , 24 (2) pp. 90-97.

Abdalla, S; Lao-Sirieix, P; Novelli, M; Lovat, LB; Fitzgerald, RC; (2004) Relationship of COX-2 expression to gastrin and cell differentiation status in Barrett's esophagus and associated carcinoma. Clinical Cancer Research , 10 pp. 4784-4792.

Abdalla, S; Sanderson, ; (2004) Variable cyclooxygenase (COX)-2 expression in Barrett's associated adenocarcinoma. Relationship to tumour differentiation. In: (pp. 223-).

Ah-See, MW; Makris, A; Taylor, NJ; Harrison, M; Ostler, PJ; Richman, PI; Stirling, JJ; ... Padhani, A; + view all (2004) Changes in dynamic contrast-enhanced MRI as an early predictor of response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 91 S22-S22.

Ah-See, MW; Padhani, AR; Taylor, NJ; Daley, FM; Bentzen, SM; Burcombe, RJ; Harrison, M; ... Makris, A; + view all (2004) Tumour microvasculature, assessment by dynamic contrast- enhanced MRI fails to correlate with VEGF expression in breast cancer biopsies. British Journal of Cancer , 91 S16-S16.

Ahmed, F; Ings, SJ; Pizzey, AR; Blundell, MP; Thrasher, AJ; Ye, HT; Fahey, A; ... Yong, KL; + view all (2004) Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model. Blood , 103 (6) pp. 2079-2087. 10.1182/blood-2003-06-1770. Green open access
file

Akbar, AN; Beverley, PCL; Salmon, M; (2004) Opinion - Will telomere erosion lead to a loss of T-cell memory? NAT REV IMMUNOL , 4 (9) 737 - 743. 10.1038/nri1440.

Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) Increased expression of the low affinity IgG receptor FcR gamma IIA (CD32) in platelet RNA from patients with chronic myeloproliferative disorders demonstrated by representational difference analysis. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 39 - 39). BLACKWELL PUBLISHING LTD

Arkenau, HT; Porschen, R; (2004) Adjuvant chemotherapy in curative resected colon carcinoma. Verdauungskrankheiten , 22 (4) pp. 208-215.

Arkenau, HT; Porschen, R; (2004) Adjuvante Therapie des kolorektalen Karzinoms. Verdauungskrankheiten pp. 208-215.

B

BBC, NO; (2004) Drug boosts lung cancer survival. UNSPECIFIED

BBC, NORCR; (2004) 'They just didn't know what it would do'. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Passive smoking is a public health hazard. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Smart drug for lung cancer tested. UNSPECIFIED

Bacon, C; Miller, R; Noursadeghi, M; McNamara, C; Du, M; Dogan, A; (2004) Pathology of bone marrow in human herpes virus-8 HHV8-associated multicentric Castleman disease. BRITISH JOURNAL OF HAEMATOLOGY , 127 (5) pp. 585-591.

Bacon, CM; Miller, RF; Noursadeghi, M; McNamara, C; Du, MQ; Dogan, A; (2004) Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease. BRIT J HAEMATOL , 127 (5) 585 - 591. 10.1111/j.1365-2141.2004.05230.x.

Balsa, C; Watts, MJ; Ings, SJ; Linch, DC; (2004) Unexpected differences in the thaw clonogenic recovery of pre-stressed peripheral blood stem cells according to the cryoprotectant used. In: BONE MARROW TRANSPLANTATION. (pp. S93 - S93). NATURE PUBLISHING GROUP

Barber, L; Whitelegg, A; Madrigal, J; Banner, N; Rose, M; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) pp. 1604-1609.

Barber, L; Whitelegg, A; on, M; igal, J; Banner, N; olas, R; (2004) Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. TRANSPLANTATION , 77 (10) pp. 1604-1609.

Bates, AW; (2004) The sooterkin doctor: the London career of John Maubray, MD (1700-1732), "andro-boethogynist". J Med Biogr , 12 (3) pp. 147-153. 10.1177/096777200401200309.

Beck, M; Cox, TM; Mehta, AB; Widmer, U; (2004) Lysosomal diseases: natural course, pathology and therapy. [Book]. (Vol.94, Su). Taylor & Francis

Beck, M; Ricci, R; Widmer, U; Dehout, F; Garciade, L; Kampmann, C; Linhart, A; ... Mehta, A; + view all (2004) Fabry disease: overall effects of agalsidase alfa treatment. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 Dec (12) pp. 838-44.

Beck, S; (2004) Dr Nat Bumstead: Pioneer researcher in mapping the chicken genome. DNA SEQUENCE , 15 (3) 165 - 166. 10.1080/10425170410001716073.

Beck, S; (2004) Haplotypes revisited: Genetic and epigenetic variation of the MHC. In: TISSUE ANTIGENS. (pp. 327 - 328). BLACKWELL MUNKSGAARD

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Melino, G; Cossarizza, A; Heery, D; (2004) Mutant PML proteins form novel cytoplasmic bodies. In: BLOOD. (pp. 952A - 952A). AMER SOC HEMATOLOGY

Benchaouir, R; Rameau, P; Decraene, C; Dreyfus, P; Israeli, D; Piétu, G; Danos, O; (2004) Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp Cell Res , 294 (1) pp. 254-268. 10.1016/j.yexcr.2003.11.005.

Bentzen, SM; Bernier, J; Khalil, AA; Saunders, MI; Horiot, JC; Van den Bogaert, W; Cummings, BJ; (2004) Estimatet effect of patient non-compliance to dose-time constraints in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Strahlentherapie und Onkologie , 180 p. 98.

Birnie, A; Gazzard, BG; Bacon, C; Dogan, A; Shaw, PJ; Miller, RF; (2004) Fever in the recently returned HIV infected traveller. SEX TRANSM INFECT , 80 (2) 86 - 90. 10.1136/sti.2003.008755.

Birtle, AJ; Newby, JC; Harland, SJ; (2004) Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British Journal of Cancer , 91 (8) pp. 1472-1476.

Bourboulia, D; Aldam, D; Lagos, D; Allen, E; Williams, I; Cornforth, D; Copas, A; (2004) Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS , 18 (3) pp. 485-493. 10.1097/00002030-200402200-00015.

Bourboulia, D.; (2004) Humoral and cellular immune responses against Kaposi's sarcoma-associated herpesvirus (KSHV). Doctoral thesis , University of London. Green open access
file

Boven, L; van, M; Boot, R; Mehta, A; Boon, L; Aerts, J; Laman, J; (2004) Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. AMERICAN JOURNAL OF CLINICAL PATHOLOGY , 122 (3) pp. 359-369.

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 105S - 105S). AMER SOC CLINICAL ONCOLOGY

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. J Clin Oncol , 22 (14_suppl) 1034-.

Bownes, P; Hoskin, PJ; Ostler, PJ; Lowe, GJ; Bryant, L; (2004) Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer. Radiotherapy and Oncology , 71 241-.

Boxall, EH; Sira, J; Standish, RA; Davies, P; Sleight, E; Dhillon, AP; Scheuer, PJ; (2004) Natural history of hepatitis B in perinatally infected carriers. ARCH DIS CHILD , 89 (5) F456 - F460. 10.1136/adc.2002.009837.

Brooks, SP; Ebenezer, N; Poopalasundaram, S; Maher, E; Francis, P; Moore, A; Hardcastle, A; (2004) Refinement of the X-linked cataract locus (CXN) and gene analysis for CXN and Nance-Horan syndrome (NHS). Ophthalmic Genet , 25 (2) pp. 121-131.

Bruno, L; Hoffman, R; McBlane, F; Brown, J; Gupta, R; Joshi, C; Pearson, S; ... Enver, T; + view all (2004) Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Molecular and Cellular Biology , 24 (2) pp. 741-756. 10.1128/MCB.24.2.741-756.2004.

Burk, K; (2004) Colonial America, the Founding Fathers and Wine. The World of Fine Wine , None (3) pp. 70-74.

Burk, K; (2004) In Greece, Drink Greek Wine. Prospect (8/04) p. 41.

Burk, K; (2004) Wine For Christmas. Prospect (1/2004) p. 45.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. LANCET ONCOL , 5 (7) 409 - 418.

Butcher, LM; Meaburn, E; Liu, L; Fernandes, C; Hill, L; Al-Chalabi, A; Plomin, R; ... Craig, IW; + view all (2004) Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav.Genet. , 34 (5) pp. 549-555. 10.1023/B:BEGE.0000038493.26202.d3.

C

Callies, S; de Alwis, DP; Mehta, A; Burgess, M; Aarons, L; (2004) Population pharmacokinetic model for daunorubicin and daunorubicinol coadministered with zosuquidar.3HCl (LY335979). Cancer Chemotherapy and Pharmacology , 54 (1) pp. 39-48.

Calvert, AH; (2004) Biochemical pharmacology of pemetrexed. Oncology (Williston Park) , 18 (13 Suppl) pp. 13-17.

Camilleri, RS; Peebles, D; Portmann, C; Everington, T; Cohen, H; (2004) -455G/A β-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagulation and Fibrinolysis , 15 (2) pp. 139-147. 10.1097/00001721-200403000-00005.

Cansick, JC; Lennon, R; Cummins, CL; Howie, AJ; McGraw, ME; Saleem, MA; Tizard, EJ; ... Taylor, CM; + view all (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative)glomerulonephritis. Nephrology Dialysis Transplantation , 19 pp. 2769-2777.

Carnell, DM; Smith, RE; Daley, FM; Barber, PR; Hoskin, PJ; Wilson, GD; Murray, GI; (2004) Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys , 58 (2) pp. 500-509.

Castillon, N; Avril-Delplanque, A; Coraux, C; Delenda, C; Péault, B; Danos, O; Puchelle, E; (2004) Regeneration of a well-differentiated human airway surface epithelium by spheroid and lentivirus vector-transduced airway cells. J Gene Med , 6 (8) pp. 846-856. 10.1002/jgm.570.

Channel, 4IMF; (2004) Happy Birthday Thalidomide. UNSPECIFIED

Chester, JD; Hall, GD; Forster, M; Protheroe, AS; (2004) Systemic chemotherapy for patients with bladder cancer - current controversies and future directions. CANCER TREATMENT REVIEWS , 30 (4) pp. 343-358. 10.1016/j.ctrv.2003.12.005.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; Boxer, G; ... Begent, R; + view all (2004) Engineering antibodies for clinical applications in cancer. Tumor Biology , 25 (1-2) pp. 91-98.

Chicken, D; Johnson, K; Falzon, M; Waddington, W; Ell, P; Bown, S; Keshtgar, M; (2004) Instantaneous detection of sentinel node metastases in breast cancer by "optical biopsy" using elastic scattering spectroscopy. In:

Chicken, D; Johnson, K; Falzon, M; Waddington, W; Ell, P; Bown, S; Keshtgar, M; (2004) Instantaneous detection of sentinel node metastases in breast cancer using elastic scattering spectroscopy. In: (pp. 37-).

Chicken, DW; Johnson, KS; Falzon, MR; Lee, AC; Briggs, G; Pickard, D; Bigio, IJ; ... Keshtgar, MR; + view all (2004) Optical biopsy utilising elastic scattering spectroscopy for intra-operative diagnosis of sentinel lymph node metastases. In: (pp. 841-).

Clingen, PH; Wu, J; Prise, KM; Hartley, JA; (2004) H2AX nuclear foci are induced in human cells after treatment with DNA interstrand crosslinking chemotherapeutics. BRITISH JOURNAL OF CANCER , 91 S48 - S48.

Coakley, M; Mallet, S; Purdy, G; Self, R; Machin, SJ; Mackie, IJ; (2004) A second cohort of patients with coronary heart disease and reduced VWF cleaving protease activity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

Cohen, H; (2004) Highlights from the 7th annual report: taking SHOT recommendations forward. [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Jones, H; Stainsby, D; (2004) SHOT 6th annual report - errors remain the predominant finding. In: (Proceedings) British society for haematology annual scientific meeting.

Cohen, H; Nash, M; Cohen, H; Liesner, R; Machin, SJ; (2004) Acquired coagulation disorders. In: Hoffbrand, V and Lewis, M and Tuddenham, E, (eds.) Postgraduate haematology.

Conde, L; Vaquerizas, JM; Santoyo, J; Al-Shahrour, F; Ruiz-Llorente, S; Robledo, M; Dopazo, J; (2004) PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. NUCLEIC ACIDS RESEARCH , 32 W242-W248. 10.1093/nar/gkh438.

Coyne, JD; Banerjee, SS; Bromley, M; Mills, S; Diss, TC; Harris, M; (2004) Post-translation T-cell lymphoproliferative disorder/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. Histopathology , 44 (4) pp. 387-393.

D

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; ... Williams, CD; + view all (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. British Journal of Haematology , 125 (6) pp. 756-765. 10.1111/j.1365-2141.2004.04981.x.

D'Sa, S; Yong, K; Kyriakou, C; Bhattacharya, S; Peggs, KS; Foulkes, B; Watts, MJ; ... Williams, CD; + view all (2004) Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects. BRIT J HAEMATOL , 125 (6) 756 - 765. 10.1111/j.1365-2141.2004.04981.x.

Damien, E; Revell, PA; (2004) Changes in distant organs in response to local osteogenic growth factors delivered by intraosseous implants: a histological evaluation. Key Engineering Materials , 254-25 pp. 797-800.

Davidoff, AM; Nathwani, AC; (2004) Antiangiogenic gene therapy for cancer treatment. Curr Hematol Rep , 3 (4) pp. 267-273.

Davies, J; Marden, C; Sviland, L; North, J; Lowdell, MW; (2004) Ex-vivo alloreactive T cell depletion with anti-CD69 - Effects on anti-viral immune-reactivity and donor NK cell function. BLOOD CELLS MOLECULES AND DISEASES , 33 (3) 198 - 198.

De Leval, L; Vivario, M; De Prijck, B; Zhou, Y; Boniver, J; Harris, NL; Isaacson, P; (2004) Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. The American Journal of Surgical Pathology , 28 pp. 679-686.

Dearling, J.L.J.; Flynn, A.A.; Sutcliffe-Goulden, J.; Petrie, I.A.; Boden, R.; Green, A.J.; Boxer, G.M.; ... Pedley, R.B.; + view all (2004) Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. The Journal of Nuclear Medicine , 45 (1) pp. 101-107.

Dhar, A; Johnson, K; Novelli, M; Bown, S; Lovat, L; Bloom, S; (2004) Optical biopsy of colonic lesions: Comparison of elastic scattering spectroscopy with histology. In: GASTROENTEROLOGY. (pp. A76 - A76). W B SAUNDERS CO

Direkze, NC; Hodivala-Dilke, K; Jeffery, R; Hunt, T; Oukrif, D; Preston, SL; Alison, MR; (2004) Bone marrow contributes to tumour stroma. In: JOURNAL OF PATHOLOGY. (pp. 10A - 10A). JOHN WILEY & SONS LTD

Diss, TC; Baginsky, L; Ye, H; Du, M; Wren, B; Dogan, A; Isaacson, PG; (2004) Campylobacter jejuni is a strong candidate for involvement in the development of immunoproliferative small intestinal disease. In: (Proceedings) 186th Meeting of the Pathological-Society-of-Great-Britain-and-Ireland/Dutch-Pathological-Society. (pp. 8A-8A). JOHN WILEY & SONS LTD

Duarte, RF; Delgado-Gonzalez, J; Shaw, BE; Wrench, D; Ethell, M; Patch, D; Dhillon, AP; ... Quaglia, AF; + view all (2004) Pathologic features may predict the clinical outcome of hepatic graft versus host disease (H-GVHD). Blood , 104 (11) 5079-.

Duke, V; Yogashangari, B; Gandini, D; Sherrington, PD; Mehta, A; Hoffbrand, AV; Foroni, L; (2004) Conserved amino acid sequences occur in a limited group of CLL patients with predominantly mutated IGH rearrangements. In: (pp. 552a-552a).

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/II dose-escalation trial evaluating the safety and tolerability of EPO906 plus capecitabine in patients with advanced cancer. J Clin Oncol , 22 (14_suppl) 2093-.

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/Il dose-escalation trial evaluating the safety and tolerability of EP0906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology , 22 (14) 2093-.

Dunham, A; Matthews, LH; Burton, J; Ashurst, JL; Howe, KL; Ashcroft, KJ; Beare, DM; ... Beck, S; + view all (2004) The DNA sequence and analysis of human chromosome 13. Nature , 425 (6960) pp. 805-811. 10.1038/nature02379.

Dunham, A.; Matthews, L.H.; Burton, J.; Ashurst, J.L.; Howe, K.L.; Ashcroft, K.J.; Beare, D.M.; ... Ross, M.T.; + view all (2004) The DNA sequence and analysis of human chromosome 13. Nature , 428 (6982) pp. 522-528. 10.1038/nature02379.

de Laat, HB; de Groot, PG; Mackie, IJ; Schoormans, S; Adam, M; Purdy, G; Woodhams, B; ... van Heerde, W; + view all (2004) The role of annexin A5 in the antiphospholipid syndrome. In: THROMBOSIS RESEARCH. (pp. 654 - 654). PERGAMON-ELSEVIER SCIENCE LTD

E

Eardley, KS; Ferreriera, MAS; Howie, AJ; Gosling, P; Lipkin, GW; (2004) Urinary albumin excretion: a predictor of glomerular findings in microscopic haematuria. QJM , 97 pp. 297-301.

Eguchi, M; Eguchi-Ishimae, M; Green, AR; Enver, T; Greaves, M; (2004) Directing oncogenic fusion genes into stem cells via an SCL enhancer. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 66A-66A). AMER SOC HEMATOLOGY

F

Ffolkes, LV; Freeman, A; Harland, SJ; Parkinson, MC; (2004) Are there diagnostic problems with testis tumours? JOURNAL OF PATHOLOGY , 204 35A - 35A.

Flanagan, J; Healey, S; Young, J; Whitehall, V; Trott, D; Newbold, R; Chenevix-Trench, G; (2004) Mapping of a candidate colorectal cancer tumour suppressor gene to a 900 kilobase region on the short arm of chromosome 8. Genes, Chromosomes and Cancer , 40 (3) pp. 247-260.

Folarin, NI; Baker, RJ; Duke, V; Yogashangary, BC; Vadikolia, C; Wickremasinghe, RG; Casanova, AA; ... Ganeshaguru, K; + view all (2004) Zap-70 and 19V(H) mutation status in combination with p53 functional analysis identifies the response of poor prognosis B-CLL patients to conventional cytotoxic agents. In: BLOOD. (pp. 527A - 528A). AMER SOC HEMATOLOGY

Forshew, T; Johnson, CA; (2004) SCAMP: a spreadsheet to collate autozygosity mapping projects. JOURNAL OF MEDICAL GENETICS , 41 (12) 10.1136/jmg.2004.023663.

Forster, MD; Madhusudan, S; Muthuramalingam, SR; Braybrooke, JP; Wilner, S; Kaur, K; Han, C; ... Harris, AL; + view all (2004) A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer. Clin Cancer Res. , 10 (19) pp. 6528-6534.

Foster, C; Evans, DGR; Eeles, R; Eccles, D; Ashley, S; Brooks, L; Cole, T; ... Watson, M; + view all (2004) Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genetic Testing , 8 (1) pp. 23-29.

Francis, RJ; Mather, SJ; Chester, K; Sharma, SK; Bhatia, J; Pedley, RB; Waibel, R; ... Begent, RHJ; + view all (2004) Radiolabelling of glycosylated MFE-23 :: CPG2 fusion protein (MFECP1) with Tc-99m for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT). EUR J NUCL MED MOL I , 31 (8) 1090 - 1096. 10.1007/s00259-004-1474-4.

G

Gaffan, J; Herbertson, R; Davis, P; Dogan, A; Jones, A; (2004) Bilateral peripheral T-cell lymphoma of the fallopian tubes. Gynecologic Oncology , 95 pp. 736-738.

Gandini, D; Allen, AJ; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. Haematologica , 89 (5) pp. 613-615. Gold open access

Gandini, D; Allen, AJR; Nash, MJ; Linch, DC; Gale, RE; (2004) No mutations in the GATA-1 gene detected in patients with acquired essential thrombocythemia. HAEMATOLOGICA , 89 (5) 613 - 615. Gold open access

Garcia, CA; Robinson, J; Madrigal, AJ; Marsh, SGE; (2004) Killer cell immunoglobulin-like receptors (KIR). In: The EBMT handbook: Haemopoitic Stem Cell Transplantation. (pp. 48-55). European School of Haematology: Paris.

Gasco, M; Sullivan, A; Smith, P; Farrell, P; Numico, G; Colantonio, I; Merlano, M; (2004) Transcriptional silencing of Fanconi anaemia genes and clinical outcome in head and neck cancer. J Clin Oncol , 22 (14_suppl) 9546-.

Geary, J; Hodgson, SV; Homfray, T; Mackay, J; Izatt, L; Dorkins, H; Thomas, H; ... Eeles, R; + view all (2004) HNPCC - Where does the buck stop? Journal of Medical Genetics , 41 S36-S36.

Gerrard, G; Butters, TD; Mehta, AB; Hoffbrand, AV; Hughes, D; Burgess, M; Ganeshaguru, K; (2004) Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity. In: BLOOD. (pp. 334A - 334A). AMER SOC HEMATOLOGY

Gerrard, G; Mitchell, W; Goldstone, A; Chopra, R; Buck, G; Richards, S; Foroni, L; (2004) Sequential quantitative minimal residual disease in BCR-ABL positive acute lymphoblastic leukaemia: Differential observations between major and minor fusion gene rearrangements and variation due to source material. In: (Proceedings) 46th Annual Meeting of the American-Society-of-Hematology. (pp. 311A-311A). AMER SOC HEMATOLOGY

Gerrard, G; Payne, E; Baker, RJ; Jones, DT; Potter, M; Prentice, HG; Ethell, M; ... Ganeshaguru, K; + view all (2004) Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. HAEMATOLOGICA , 89 (7) pp. 782-790. Gold open access

Giampieri, S; Storey, A; (2004) Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from humanpapillomaviruses types 5 and 18. BRIT J CANCER , 90 (11) 2203 - 2209. 10.1038/sj.bjc.6601829.

Ginhoux, F; Turbant, S; Gross, DA; Poupiot, J; Marais, T; Lone, Y; Lemonnier, FA; ... Davoust, J; + view all (2004) HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther , 10 (2) pp. 279-289. 10.1016/j.ymthe.2004.05.012.

Ginsberg, L; Beck, M; Ricci, R; Widmer, U; Mehta, A; (2004) Central nervous system manifestations of Fabry disease: experience from FOS, the Fabry Outcome Survey. JOURNAL OF NEUROLOGY , 251 p. 23.

Ginsberg, L; Richfield, L; Goodwin, S; Milligan, A; Valentine, A; Kendall, B; Zuckerman, J; (2004) Brain MRI appearances in Fabry disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 75 (5) 057-.

Godfrey, A; Anderson, J; Papanastasiou, A; Takeuchi, Y; Boshoff, C; (2004) Related ArInhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood

Gomez, K; Laffan, MA; (2004) Hunting for the mutation in inherited thrombophilia. Blood Coagul Fibrinolysis , 15 (2) pp. 125-127.

Goyenvalle, A; Vulin, A; Fougerousse, F; Leturcq, F; Kaplan, J-C; Garcia, L; Danos, O; (2004) [An opening in Duchenne muscular dystrophy: persistent therapeutic rescue of dystrophin by vectorized antisense mediated exon skipping in mdx mice]. Med Sci (Paris) , 20 (12) pp. 1163-1165. 10.1051/medsci/200420121163.

Grafone, T; Mancini, M; Ottaviani, E; Renzulli, M; Boschelli, F; Ferraretti, L; Santucci, MA; ... Martinelli, G; + view all (2004) A novel 4-anilino-3-quinolinecarbonitrile dual sre and AbI kinase inhibitor (SKI-606) has in vitro activity on CML Ph plus Blast cells resistant to imatinib. In: BLOOD. (pp. 549A - 550A). AMER SOC HEMATOLOGY

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; ... Burroughs, AK; + view all (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. Journal of Hepatology , 40 130-.

Grasso, A; Stigliano, R; Morisco, F; Quaglia, A; Dhillon, AP; Davidson, B; Rolles, K; ... Burroughs, AK; + view all (2004) Hepatocellular carcinoma treated by orthotopic liver transplantation: Prediction for recurrence. Gut , 53 A119-A119.

Gray, JT; Davidoff, AM; Nathwani, AC; (2004) A novel human factor IX expression cassette packaged as self-complementary DNA dimers in adeno-associated virus vectors results in dramatically improved liver transduction, significantly improving prospects for hemophilia B gene therapy. In: BLOOD. (pp. 869A - 869A). AMER SOC HEMATOLOGY

Green, A; Flynn, A; Pedley, RB; Dearling, J; Begent, R; (2004) Nonuniform absorbed dose distribution in the kidney: The influence of organ architecture. Cancer Biotherapy and Radiopharmaceuticals , 19 (3) pp. 371-377. 10.1089/1084978041425052.

Grimwade, D; Gale, R; Hills, R; Kottaridis, P; Swirsky, D; Gilkes, A; Nugent, E; ... NCRI Adult Leukaemia Working Party, ; + view all (2004) The relationship between FLT3 mutation status, biological characteristics and outcome in patients with acute promyelocytic leukaemia. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 69 - 69). BLACKWELL PUBLISHING LTD

Guinn, BA; Gilkes, AF; Mufti, GJ; Linch, D; Burnett, AK; Mills, KI; (2004) Use of cDNA microarray analysis to identify cancer testes antigen expression in presentation acute myeloid leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 125 51-.

H

Hackshaw, A; (2004) Tobacco Smoke and Involuntary Smoking (A Hackshaw member of expert working group). WHO/IARC, Lyon, France

Hackshaw, AK; (2004) Tobacco and other disorders. In: Boyle, P and Gray, N and Henningfield, J and Seffrin, J and Zatonski, W, (eds.) Tobacco: The Public Health Disaster of the Twentieth Century. (pp. 593-619). Oxford University Press

Hackshaw, AK; Sweetenham, J; Knight, A; (2004) Are hematopietic growth factors worthwhile in the management of previously untreated patients with high-grade non-Hodgkin’s lymphoma? British Journal of Cancer , 90 pp. 1302-1305.

Hall, C; (2004) Screening for gullet cancer may save lives. Telegraph Media Group, London, UK.

Hallowell, N; Mackay, J; Richards, M; Gore, M; Jacobs, I; (2004) High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: A descriptive study. Genetic Testing , 8 (2) pp. 148-156.

Hampel, C.; (2004) Deregulation of E2f-1 and chemosensitivity. Doctoral thesis , University of London. Green open access
file

Harbord, M; Marks, DJB; Oukrif, D; Novelli, M; Segal, AW; Bloom, S; (2004) A novel method to investigate the inflammatory response in the bowel, and confirmation of its impairment in Crohn's disease. In: GUT. (pp. A103 - A103). B M J PUBLISHING GROUP

Harney, J; Shah, N; Short, S; Daley, F; Groom, N; Wilson, GD; Joiner, MC; (2004) The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiotherapy and Oncology , 70 (3) pp. 319-329. 10.1016/j.radonc.2004.01.015.

Harney, J; Short, S; Shah, N; Joiner, M; Saunders, MI; (2004) Low dose hyper-radiosensitivity in metastatic tumors. International Journal of Radiation Oncology Biology Physics , 59 (4) pp. 1190-1195. 10.1016/j.ijrobp.2003.12.029.

Hartley, J.A.; Spanswick, V.J.; Brooks, N.; Clingen, P.H.; McHugh, P.J.; Hochhauser, D.; Pedley, R.B.; ... Thurston, D.E.; + view all (2004) SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Cancer Research , 64 (18) pp. 6693-6699.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. Mutagenesis , 19 (6) 15-.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. MUTAGENESIS , 19 (6) 504 - 504.

Haynes, SVZ; Dudderidge, TJ; (2004) Emergency contraception: the journey so far. BJOG-INT J OBSTET GY , 111 (1) 91 - 91. 10.1046/j.1471-5028.2003.00020.x.

Helena Selby, BBCWSABBCR4; (2004) BBC World Service Health Matters Programme on Lung Cancer. UNSPECIFIED

Henderson, SR; Reuss, H; Hardie, RC; (2004) Single photon responses in Drosophila photoreceptors and their regulation by Ca2+. The Journal of physiology , 524 (1) pp. 179-194.

Hernandez, D; Addou, S; Lee, D; Orengo, C; Shephard, EA; Phillips, IR; (2004) Trimethylaminuria and a human FMO3 mutation database. Human Mutation , 22 (3) pp. 209-213.

Hernandez, D; Janmohamed, A; Chandan, P; Phillips, IR; Shephard, EA; (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics , 14 (2) pp. 117-130.

Hing, KA; Saeed, S; Annaz, B; Buckland, T; Revell, PA; (2004) Microporosity affects bioactivity of macroporous hydroxyapatite bone graft substitutes. Key Engineering Materials , 254-25 pp. 273-276.

Hollyman, D.R.; (2004) Cellular targets of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. Doctoral thesis , University of London. Green open access
file

Hoskin, PJ; (2004) The RIB trial. Clinical Oncology , 16 (7) pp. 445-446.

Hoskin, PJ; (2004) Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against. Clinical Oncology , 16 (2) pp. 112-114.

Hoskin, PJ; Decanha, SM; P, G-J; R, ; (2004) High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Radiotherapy and Oncology , 73 pp. 195-198.

Hoskin, PJ; Sibtain, A; Daley, FM; Saunders, MI; Wilson, GD; (2004) The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiotherapy and Oncology , 72 (2) pp. 159-168.

Hough, RE; Faulkner, RD; Welch, JC; Vora, AJ; (2004) Efficacy of unrelated donor cord blood transplantation for poor risk paediatric haematological malignancies. In: (Proceedings) 30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group. (pp. S126-S127). NATURE PUBLISHING GROUP

Howie, AJ; (2004) Defining the role of pathology services in the diagnosis and staging of renal cell carcinoma. In: Aitchison, M and Oliver, RTD and Miles, A, (eds.) The Effective Management of Renal Cell Carcinoma. (pp. 49-53). Aesculapius Medical Press: London.

Howie, AJ; Adu, D; (2004) Different meanings of 'glomerular tip lesion'. Kidney International , 66 1716-.

Howie, AJ; Ferreira, MAS; Lipkin, GW; Adu, D; (2004) Measurement of chronic damage in the donor kidney and graft survival. Transplantation , 77 pp. 1058-1065. 10.1097/01.TP.0000120177.44144.FF.

Hughes, DA; Baker, RJ; Richfield, L; Milligan, A; Bruce, R; Mehta, AB; (2004) Balanced oral substrate reduction therapy for patients with mild to moderate Gaucher's disease: Initial results in clinical practice. In: BLOOD. (pp. 41B - 42B). AMER SOC HEMATOLOGY

Hughes, DA; Baker, RJ; Wright, F; Mehta, AB; (2004) The hypergammaglobinaemia of Gauchers disease is not reversed by enzyme replacement therapy. BRITISH JOURNAL OF HAEMATOLOGY , 125 p. 59.

Hughes, DA; Li, A; Keshav, S; Mehta, A; (2004) Hepcidin dysregulation in patients with type 1 Gaucher's disease. In: BLOOD. (pp. 42B - 43B). AMER SOC HEMATOLOGY

Hughes, DA; Mehta, AB; (2004) Abnormal distribution of cell surface receptors in glycosphingolipid storage disorders: an in vitro model of Gaucher's and Fabry disease. BRITISH JOURNAL OF HAEMATOLOGY , 125 59 - 59.

Hughes, SE; (2004) The pathology of hypertrophic cardiomyopathy. Histopathology , 44 pp. 412-427.

Huhalov, A; Spencer, DIR; Chester, KA; (2004) A strategy for characterizing antibody/antigen interactions using proteinchip arrays. In: Conn, PM, (ed.) Handbook of proteomic methods. (pp. 117-128). Humana Press: New Jersey.

I

Irshad, S.; Pedley, R.B.; Anderson, J.; Latchman, D.S.; Budhram-Mahadeo, V.; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. Journal of Biological Chemistry , 279 (20) pp. 21617-21627. 10.1074/jbc.M312506200. Gold open access

Irshad, S.; Pedley, R.B.; Anderson, J.; Latchman, D.S.; Budhram-Mahadeo, V.; (2004) The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. Journal of Biological Chemistry , 279 (20) p. 21617. 10.1074/jbc.M312506200. Gold open access

Isaacson, PG; Du, MQ; (2004) Timeline: MALT lymphoma: from morphology to molecules. Nature Reviews Cancer , 4 pp. 644-653.

J

Jakupovic, I; Grandage, VL; Linch, DC; Khwaja, A; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. BLOOD , 103 (8) 3230 - 3232.

Jakupovic, I.; Grandage, V.L.; Linch, D.C.; Khwaja, A.; (2004) Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells. Blood , 103 (8) pp. 3230-3232. 10.1182/blood-2003-06-1985. Green open access
file

Janeway, C; Travers, P; Walport, M; Shlomick, M; (2004) Immunobiology: The immune system in health and disease. [Book]. (1 vols). (6th ed.). Garland Science: New York.

Jennings, BH; Shah, S; Yamaguchi, Y; Seki, M; Phillips, RG; Handa, H; Ish-Horowicz, D; (2004) Locus-specific requirements for Spt5 in transcriptional activation and repression in Drosophila. Curr Biol , 14 (18) pp. 1680-1684. 10.1016/j.cub.2004.08.066.

Jia, L; Spanswick, VJ; Reid, JM; Kuffel, M; Buhrow, SA; Ames, MM; Hartley, JA; ... Tomaszewski, JE; + view all (2004) Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes. Proceedings of the American Association for Cancer Research , 45 1969-.

Jones, DT; Addison, E; North, JM; Lowdell, MW; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; ... Wickremasinghe, RG; + view all (2004) Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs. BLOOD , 103 (5) 1855 - 1861. 10.1182/blood-2003-05-1603.

K

Kakkar, AK; Bundred, N; Carpenter, R; Makris, A; Merriman, H; Walker, ID; (2004) Venous thromboembolism in cancer patients. Guidelines. EGUIDELINES , 23 pp. 311-314.

Kalra, D; Singleton, P; Ingram, D; Milan, J; MacKay, J; Detmer, D; Rector, A; (2004) Security and confidentiality approach for the Clinical E-ScienceFramework (CLEF). In: (Proceedings) Health Grid 2004. : Clermont-Ferrand, France.

Kiakos, K; Hartley, JA; Price, C; Lingerfelt, B; Handl, H; Lee, M; (2004) Design, synthesis and DNA alkylation specificity of novel achiral seco-CI-polyamide hairpin conjugates. Proceedings of the American Association for Cancer Research , 45 3091-.

Kiakos, K; Mchugh, PJ; Hartley, JA; Sato, K; Summerville, K; C, L; M, ; (2004) Design, synthesis and biological evaluation of AS-I-145, a novel achiral amino seco-CBI. Proceedings of the American Association for Cancer Research , 45 3998-.

Kim, JB; O'Hare, MJ; Stein, R; (2004) Models of breast cancer: is merging human and animal models the future? BREAST CANCER RESEARCH , 6 (1) pp. 22-30. 10.1186/bcr645.

Kooistra, K; Zhang, YH; Henriquez, NV; Weiss, B; Mumberg, D; Noteborn, MH; (2004) TT virus-derived apoptosis-inducing protein induces apoptosis preferentially in hepatocellular carcinoma-derived cells. pp. 1445-1450.

Kroeger, N; Shaw, B; Iacobelli, S; Zabelina, T; Peggs, K; Shimoni, A; Nagler, A; ... Marks, D; + view all (2004) Comparison between anti-thymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch in melphalan/fludarabine dose-reduced conditioning followed by HLA-matched and mismatched unrelated stem cell transplantation in patients with multiple myeloma. In: BLOOD. (pp. 280A - 281A). AMER SOC HEMATOLOGY

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; Townes, H; ... Lee, M; + view all (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Bioorganic and Medicinal Chemistry , 12 (23) pp. 6221-6236.

L

Ladesmaki, A; Kimby, E; Duke, V; Foroni, L; Hammarstroem, L; (2004) ATM mutations in B-cell chronic lymphocytic leukemia. HAEMATOLOGICA , 89 (1) pp. 109-110. Gold open access

Lajmi, AR; Sleep, S; Ng, C; Zhou, JF; Spence, YY; Davidoff, AM; Nathwani, AC; (2004) Scaleable membrane chromatography purification method for adeno-associated viral vectors. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U237 - U237). AMER CHEMICAL SOC

Lankester, KJ; Maxwell, RJ; Pedley, RB; Hill, SA; Rustin, GJS; Tozer, GM; (2004) Acute anti-vascular effects of combretastatin A4 phosphate (CA-4-P) on the SW1222 tumour as measured by dynamic contrast enhanced (DCE)-MRI. BRITISH JOURNAL OF CANCER , 91 S16 - S16.

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. Mutagenesis , 19 (6) 51-.

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. MUTAGENESIS , 19 (6) 516 - 516.

Leonard, RCF; Lind, M; Twelves, C; Coleman, R; van Belle, S; Wilson, C; Ledermann, J; ... Crown, J; + view all (2004) Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: A randomized trial. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE , 96 (14) pp. 1076-1083. 10.1093/jnci/djh188.

Litchfield, TM; Gilchrist, S; Sunderland, R; Folkard, M; Short, S; Prise, K; (2004) A three dimensional tissue culture model for microbeam studies. In: (pp. P 462.4-).

Liu, WM; Strauss, SJ; Chaplin, T; Shahin, S; Propper, DJ; Young, BD; Joel, SP; (2004) s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. Hematol J , 5 (3) 247-54-247-54.

M

MacGregor, A; Hackshaw, A; (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology , 63 pp. 351-353.

Maccioni, RB; Lavados, M; Maccioni, CB; Mendoza-Naranjo, A; (2004) Biological markers of Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res , 1 (4) pp. 307-314.

Mackie, I; Yarranton, H; Machin, S; Pinkoski, L; Corash, L; (2004) Von Willebrand factor cleaving protease is retained in intercept plasma. In: TRANSFUSION. (pp. 102A - 102A). BLACKWELL PUBLISHING INC

Mackie, IJ; de Laat, HB; Purdy, G; Adam, M; Woodhams, B; Derksen, RHWM; de Groot, PG; (2004) A prototype commercial ELISA for protein S antibodies. In: THROMBOSIS RESEARCH. (pp. 639 - 639). PERGAMON-ELSEVIER SCIENCE LTD

Madrigal, A; Rusakiewicz, S; Dodi, A; I, R; Robert, ; (2004) Immunotherapy with alloreactive T-cells? THE HEMATOLOGY JOURNAL , 5 (Suppl 3) S91-S95.

Makris, A; (2004) Critical commentary of: HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. Women's Oncology Review , 4 pp. 277-278.

Makris, A; (2004) Critical commentary of: Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. Women's Oncology Review , 4 pp. 213-214.

Makris, A; Glynne-Jones, R; Sebag-Montefiore, D; Samuel, L; Myint, S; Levine, E; Martin, A; (2004) Compliance to chemotherapy with oxaliplatin and 5fluorouracil in patients with advanced rectal cancer who rave received prior high-dose pelvic radiotherapy. British Journal of Cancer , 91 S34-S34.

Markandaya, M; Ramesh, TK; Selvaraju, V; Dorairaj, SK; Prakash, R; Shetty, J; Kumar, A; (2004) Genetic analysis of an Indian family with members affected with juvenile-onset primary open-angle glaucoma. Ophthalmic Genet , 25 (1) pp. 11-23.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update August 2004. Tissue Antigens , 64 (6) pp. 711-712. 10.1111/j.1399-0039.2004.00334.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update August 2004. Eur J Immunogenet , 31 (6) 279-. 10.1111/j.1365-2370.2004.00485.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Eur J Immunogenet , 31 (2) 101-. 10.1111/j.1365-2370.2004.00453.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update February 2004. Tissue Antigens , 64 (1) pp. 106-107. 10.1111/j.1399-0039.2004.00265.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Eur J Immunogenet , 31 (2) 99-. 10.1111/j.1365-2370.2004.00451.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Tissue Antigens , 63 (6) pp. 619-620. 10.1111/j.0001-2815.2004.00254.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update January 2004. Hum Immunol , 65 (7) 767-. 10.1016/j.humimm.2004.05.005.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update July 2004. Hum Immunol , 65 (11) pp. 1411-1412. 10.1016/j.humimm.2004.09.013.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update June 2004. Hum Immunol , 65 (11) pp. 1409-1410. 10.1016/j.humimm.2004.09.012.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Eur J Immunogenet , 31 (2) 103-. 10.1111/j.1365-2370.2004.00454.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update March 2004. Tissue Antigens , 64 (1) pp. 108-109. 10.1111/j.1399-0039.2004.00266.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2003. Hum Immunol , 65 (1) pp. 90-91.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2003. Tissue Antigens , 63 (2) pp. 190-191.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2004. Tissue Antigens , 64 (6) pp. 713-714. 10.1111/j.1399-0039.2004.00335.x.

Marsh, SGE; (2004) Nomenclature for factors of the HLA system, update September 2004. Eur J Immunogenet , 31 (6) 281-. 10.1111/j.1365-2370.2004.00486.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update April 2004. Eur J Immunogenet , 31 (4) pp. 195-196. 10.1111/j.1365-2370.2004.00468.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update August 2003. Tissue Antigens , 63 (1) pp. 98-99.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update December 2003. Tissue Antigens , 63 (5) pp. 505-506. 10.1111/j.1399-0039.2004.00213.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update July 2003. Tissue Antigens , 63 (1) pp. 96-97.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update June 2004. Eur J Immunogenet , 31 (4) pp. 199-200. 10.1111/j.1365-2370.2004.00472.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update May 2004. Eur J Immunogenet , 31 (4) pp. 197-198. 10.1111/j.1365-2370.2004.00469.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update November 2003. Tissue Antigens , 63 (5) pp. 503-504. 10.1111/j.0001-2815.2004.00212.x.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2004) Nomenclature for factors of the HLA system, update October 2003. Tissue Antigens , 63 (5) pp. 501-502. 10.1111/j.0001-2815.2004.00211.x.

Martin, HM; Moore, KP; Bosmans, E; Davies, S; Burroughs, AK; Dhillon, AP; Tosh, D; (2004) Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver. FREE RADICAL BIO MED , 37 (8) 1214 - 1223. 10.1016/j.freeradbiomed.2004.06.045.

Martinelli, G; Martelli, AM; Grafone, T; Rosti, G; Mantovani, I; Cappellini, A; Tazzari, PL; ... Baccarani, M; + view all (2004) A new abl kinase inhibitor (AMN107) has in vitro activity on CML Ph plus Blast cells resistant to imatinib. In: BLOOD. (pp. 255B - 255B). AMER SOC HEMATOLOGY

Mathias, MC; Mackie, I; Khair, K; Machin, SJ; Liesner, R; (2004) Defective fibrinolysis in children with severe haemophilia A. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 45 - 45). BLACKWELL PUBLISHING LTD

May, G; Enver, T; (2004) The Genetic Regulation of Stem Cell Fate. In: Handbook of Stem Cells. (pp. 83-93).

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; ... Begent, RHJ; + view all (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. British Journal of Cancer , 91 S8-S8.

Mayor, NP; Cox, ST; McWhinnie, AJ; Arguello, JR; Shaw, BE; Little, A-M; Madrigal, JA; (2004) Sequence of a novel HLA-A*0301 intronic variant (A*03010103). TISSUE ANTIGENS , 65 pp. 107-109.

McCabe, DJH; Harrison, P; Sidhu, PS; Mackie, IJ; Purdy, G; Lawrie, AS; Watt, H; ... Brown, MM; + view all (2004) Leucocyte-platelet complex formation is increased in patients with acute symptomatic compared with asymptomatic severe carotid stenosis. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 522 - 522). B M J PUBLISHING GROUP

McGurk, CJ; Cummings, M; Hartley, JA; Masters, JR; (2004) Translational regulation of ERCC1 in human cancer cell lines. Proceedings of the American Association for Cancer Research , 45 2631-.

McMeish, I; Kanfer, EJ; Haynes, R; Giles, C; Harland, SJ; Driver, D; Rustin, GJS; ... Seckl, MJ; + view all (2004) Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. British Journal of Cancer , 90 (6) pp. 1169-1175.

McStay, MK; Khan, K; Savage, K; Stubbs, M; Dhillon, AP; Caplin, M; (2004) Neuroendocrine-like differentiation in hepatocellular and pancreatic cancers. In: GASTROENTEROLOGY. (pp. A494 - A494). W B SAUNDERS CO

McTiernan, A; Whelan, JS; (2004) A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma , 8 (2-3) pp. 71-76. 10.1080/13577140410001711764. Gold open access

Mchugh, PJ; Hartley, JA; (2004) Repair of DNA interstrand crosslinks Produced by Cancer Chemotherapeutic Drugs. In: Panasci, LC and Alaoui-Jamali, MA, (eds.) DNA Repair in Cancer Therapy. (pp. 31-49). Humana Press: Totowa. NJ.

Mehta, A; Beck, M; Ricci, R; Widmer, U; (2004) Fabry disease defined: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (6) p. 450.

Mehta, A; Beck, M; Ricci, R; Widmer, U; Sunder-Plassmann, G; (2004) Fabry outcome survey: need for documentation of dermatological, ophthalmologic and psychiatric affections: authors' reply. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (7) p. 517.

Mehta, A; Ricci, R; Widmer, U; Dehout, F; Garcia, D; Kampmann, C; Linhart, A; ... Beck, M; + view all (2004) Fabry disease defined: Baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , 34 (3) pp. 236-242.

Meja, KK; Catley, MC; Cambridge, LM; Barnes, PJ; Lum, H; Newton, R; Giembycz, MA; (2004) Adenovirus-mediated delivery and expression of a cAMP-dependent protein kinase inhibitor gene to BEAS-2B epithelial cells abolishes the anti-inflammatory effects of rolipram, salbutamol, and prostaglandin E2: a comparison with H-89. J Pharmacol Exp Ther , 309 (2) pp. 833-844. 10.1124/jpet.103.060020.

Melichar, B; Casado, E; Tabemero, J; Hosseinzadeh, S; Hamm, J; Wadler, S; Bridgewater, J; ... Johri, A; + view all (2004) Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer. In: (pp. p. 85). OXFORD UNIV PRESS

Morris, E.; Thomson, K.; Craddock, C.; Mahendra, P.; Milligan, D.; Cook, G.; Smith, G.M.; ... Mackinnon, S.; + view all (2004) Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. Blood , 104 (13) pp. 3865-3871. 10.1182/blood-2004-03-1105. Green open access
file

Morsi, H; Yong, KL; Jewell, AP; (2004) Evaluation of the Taguchi methods for the simultaneous assessment of the effects of multiple variables in the tumour microenvironment. International Seminars in Surgical Oncology , 1 10.1186/1477-7800-1-7.

Munker, R; Schmid, C; Madrigal, JA; Kolb, HJ; (2004) An update on graft-versus-host and graft-versus-leukemia reactions: a summary of the sixth International Symposium held in Schloss Ellmau, Germany, January 22-24, 2004. BONE MARROW TRANSPLANTATION , 34 (9) pp. 767-780.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; Thomson, MA; ... Walker-Smith, JA; + view all (2004) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children (Retraction of vol 351, pg 637, 1998). LANCET , 363 (9411) 750 - 750.

Murch, SH; Anthony, A; Casson, DH; Malik, M; Berelowitz, M; Dhillon, AP; Thomson, MA; ... Walker-Smith, JA; + view all (2004) Retraction of an interpretation. Lancet , 363 (9411) 750-. 10.1016/S0140-6736(04)15715-2.

N

Nacheva, E; Brazma, D; Grace, C; (2004) The genetic profile of CML-new revelations with matrix CGH. In: (pp. 805A-806A).

Narat, S; Gandla, J; Mehta, A; (2004) Anti-CD20 monoclonal antibody in the treatment of refractory auto-immune cytopenias in adults. In: (pp. 742a-742a).

Nash, M; Camilleri, R; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: (Proceedings) British society for haematology annual scientific meeting.

Nash, M; Camilleri, R; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta2GP1/Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: (Proceedings) British society for haematology annual scientific meeting.

Nash, MJ; Camilleri, RS; Everington, T; Cohen, H; (2004) An analysis of the antiphospholipid antibody status of 111 women with late pregnancy morbidity. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 49). BLACKWELL PUBLISHING LTD

Nash, MJ; Camilleri, RS; Mackie, IJ; Machin, SJ; Cohen, H; (2004) An analysis of the beta(2)-glycoprotein I Cys306Gly polymorphism in patients with thrombotic and obstetric disorders. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 48 - 48). BLACKWELL PUBLISHING LTD

Nathwani, AC; Benjamin, R; Nienhuis, AW; Davidoff, AM; (2004) Current status and prospects for gene therapy. VOX SANG , 87 (2) 73 - 81.

Nicholls, BM; Bredius, R; Nesbitt, SA; Horton, MA; Flanagan, AM; (2004) Limited evidence of rescue of osteoclast-poor osteopetrosis following successful engraftment by cord blood from an unrelated donor. In: (Proceedings) Annual Meeting of the Bone-and-Tooth-Society. (pp. p. 1034). WILEY-BLACKWELL

Nicholls, BM; Bredius, RG; Nesbitt, SA; Horton, MA; Flanagan, AM; (2004) LITTLE EVIDENCE OF RESCUE OF OSTEOCLAST-POOR OSTEOPETROSIS FOLLOWING 'SUCCESSFUL ENGRAFTMENT' BY CORD BLOOD FROM AN UNRELATED DONOR. CALCIFIED TISSUE INTERNATIONAL , 74 S64-S64.

Novak-Hofer, I; Waibel, R; Zimmermann, K; Schibli, R; Grünberg, ; J, ; Chester, ; ... P, A; + view all (2004) Radiometal labeling of antibodies and antibody fragments for imaging and therapy. In: Methods Mol Biol. (pp. 481-494). Humana Press

O

O'Connell, NM; McIntosh, JH; Riddell, A; Pascoe, G; Griffioen, A; Lee, CA; Perry, DJ; (2004) Thrombin generation and correlation with bleeding tendency in inherited FXI deficiency. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 44 - 44). BLACKWELL PUBLISHING LTD

O'Donnell, A; Judson, I; Dowsett, M; Raynaud, F; Dearnaley, D; Mason, M; Harland, S; ... Jarman, M; + view all (2004) Hormonal impact of the 17 alpha-hydroxylase/C-17,C-20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. British Journal of Cancer , 90 (12) pp. 2317-2325.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Circulation Research , 95 (4) pp. 380-388.

Okorokov, AL; Orlova, EV; Kingsbury, SR; Bagneris, C; Gohlke, U; Williams, GH; Stoeber, K; (2004) Molecular structure of human geminin. NAT STRUCT MOL BIOL , 11 (10) 1021 - 1022. 10.1038/nsmb835.

Orteu, CH; Jansen, T; Beck, M; Mehta, A; Ricci, R; Widmer, U; (2004) The Fabry Outcome Survey is a useful tool to document the natural history of Fabry disease. British Journal of Dermatology , 151 p. 9.

P

Papazisis, KT; Habeshaw, T; Miles, DW; (2004) Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , 58 (6) pp. 581-586. 10.1111/j.1368-5031.2004.00203.x.

Parini, R; Ramaswami, U; Whybra, C; Mehta, A; Ricci, R; Widmer, U; Beck, M; (2004) Diagnosis of Anderson-Farry disease in childhood. What should we focus on? Pediatric Research , 56 (3) 207-.

Parker, LL; Lacy, SM; Farrugia, LJ; Evans, C; Robins, DJ; O'Hare, CC; Hartley, JA; ... Stratford, IJ; + view all (2004) A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs. J MED CHEM , 47 (23) 5683 - 5689. 10.1021/jm0449866w.

Parsonnet, J; Isaacson, PG; (2004) Bacterial infection and MALT lymphoma. The New England Journal of Medicine , 350 pp. 213-215. 10.1056/NEJMp038200. Green open access
file

Paston, SJ; Dodi, IA; Madrigal, JA; (2004) Progress made towards the development of a CMV peptide vaccine. HUM IMMUNOL , 65 (5) pp. 544-549.

Paston, SJ; Dodi, IA; Madrigal, JA; (2004) Progress made towards the development of a CMV peptide vaccine. HUMAN IMMUNOLOGY , 65 (5) pp. 544-549.

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Peggs, KS; (2004) Cytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy. Expert Rev Anti Infect Ther , 2 (4) pp. 559-573.

Peltenburg, LTC; de Bruin, EC; Meersma, D; Wilting, S; Jürgensmeier, JM; Schrier, PI; (2004) c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers. Melanoma Res , 14 (1) pp. 3-12.

Phair, RD; Scaffidi, P; Elbi, C; Vecerova, J; Dey, A; Ozato, K; Brown, DT; ... Misteli, T; + view all (2004) Global Nature of Dynamic Protein-Chromatin Interactions In Vivo: Three-Dimensional Genome Scanning and Dynamic Interaction Networks of Chromatin Proteins. Molecular and Cellular Biology , 24 (14) pp. 6393-6402. 10.1128/MCB.24.14.6393-6402.2004.

Pileri, SA; Sabattini, E; Agostinelli, C; Bodega, L; Rossi, M; Zinzani, PL; Marafioti, T; (2004) Histopathology of B-cell chronic lymphocytic leukemia. In: UNSPECIFIED (807-+). W B SAUNDERS CO

Poerio, A; Amabile, M; Soverini, S; Renzulli, M; Rosti, G; Bassi, S; Ottaviani, E; ... Martinelli, G; + view all (2004) Down regulation of TOPK, PBX3, SRPK, DDX21 and CLC genes in newly diagnosed, early-chronic phase chronic myeloid leukemia patients treated with imatinib mesylate. In: BLOOD. (pp. 246B - 246B). AMER SOC HEMATOLOGY

Porakishvili, N; Kardava, L; Jewell, AP; Yong, K; Glennie, MJ; Akbar, A; Lydyard, PM; (2004) Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway. Haematologica , 89 (4) pp. 435-443. Gold open access

Porakishvili, N; Kulikova, N; Manoussaka, M; Jewell, AP; Youinou, PY; Nedelec, S; Yong, K; ... Lydyard, PM; + view all (2004) Differential expression of CD180 and sIgM by B chronic lymphocytic leukaemia cells (B-CLL) using mutated and unmutated IgVh genes. In: BLOOD. (pp. 768A - 768A). AMER SOC HEMATOLOGY

Porakishvili, N; Manoussaka, M; Kulikova, N; Walton, J; Nathwani, A; Jewell, AP; Stevenson, F; ... Lydyard, PM; + view all (2004) Activation and proliferation of B cell chronic lymphocytic leukaemia (B-CLL) cells through anti-CD180, Anti-CD40 and IL-4. In: BLOOD. (pp. 277B - 277B). AMER SOC HEMATOLOGY

Preston, SL; Oukrif, D; Kyriakides, A; Elia, G; Novelli, M; Direkze, N; Talbot, IC; ... Wright, NA; + view all (2004) Modes of growth of colorectal adenomas (flat and polypoid): Evidence against 'top-down' as a major method of expansion. In: JOURNAL OF PATHOLOGY. (pp. 11A - 11A). JOHN WILEY & SONS LTD

Preston, SL; Oukrif, D; Kyriakides, A; Elia, G; Novelli, M; Direkze, NC; Talbot, IC; (2004) Flat adenomas in the colon originate in monocryptal adenomas and clonally expand by superficial budding without significant "top down" spread. In: GUT. (pp. A20 - A20). B M J PUBLISHING GROUP

Preston, SL; Oukrif, D; Kyriakides, A; Elia, G; Talbot, IC; Tomlinson, IP; Direkze, NC; ... Wright, NA; + view all (2004) Patterns of beta-catenin staining and downstream targets of beta-catenin/TCF/LEF transcription reveal modes of growth of colorectal adenomas: Evidence against "top down" as a major component of clonal expansion. In: GUT. (pp. A29 - A29). B M J PUBLISHING GROUP

R

Raslova, H; Komura, E; Le Couédic, JP; Larbret, F; Debili, N; Feunteun, J; Danos, O; ... Favier, R; + view all (2004) FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest , 114 (1) pp. 77-84. 10.1172/JCI21197.

Reid, AG; Nacheva, EP; (2004) A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. In: LEUKEMIA. (pp. 178 - 180). NATURE PUBLISHING GROUP

Roberts, CH; Robinson, J; Dodi, IA; Madrigal, JA; Marsh, SGE; (2004) The European searchable tumour cell line database (ESTDAB). Genes and Immunity , 5 44-.

Roberts, CH; Robinson, J; Dodi, IA; Madrigal, JA; Marsh, SGE; (2004) The European searchable tumour cell line database (ESTDAB). In: (Proceedings) 18th European Histocompatibility Conference. (pp. S11-S11). NATURE PUBLISHING GROUP

Robinson, J; Garcia, CA; Waller, MJ; Madrigal, JA; Marsh, SGE; (2004) The immuno polymorphism database. In: (Proceedings) 18th European Histocompatibility Conference. (pp. S11-S11). NATURE PUBLISHING GROUP

Rusakiewicz, S; Dodi, IA; Loconto, J; Travers, PJ; Madrigal, JA; (2004) Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells, Molecules, and Diseases , 33 (3) p. 191.

Rusakiewicz, S; Dodi, IA; Loconto, J; Travers, PJ; Madrigal, JA; (2004) Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells, Molecules, and Diseases , 33 (3) p. 191.

S

Samonakis, DN; Thalheimer, U; Quaglia, A; Mela, M; Triantos, CK; Dhillon, AP; Leandro, G; ... Burroughs, AK; + view all (2004) Prospective evaluation of hepatic venous pressure and evolution of recurrent HCV after liver transplantation. HEPATOLOGY , 40 (4) 362A - 362A.

Samonakis, DN; Triantos, CK; Thalheimer, U; Quaglia, A; Leandro, G; Papatheodoridis, GV; Teixeria, R; ... Burroughs, AK; + view all (2004) Donor age does not influence progression of HCV recurrence after liver transplantation. Journal of Hepatology , 40 14-.

Saunders, MI; Rojas, AM; (2004) Management of cancer of the head and neck--a cocktail with your PORT? N Engl J Med , 350 (19) pp. 1997-1999. 10.1056/NEJMe048038.

Self, R; Mackie, I; Jenkins, A; Sanders, J; Williams, A; Machin, S; Mythen, M; (2004) Use of the Thrombelastograph (R) to assess the in vitro effects of DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass. In: BRITISH JOURNAL OF ANAESTHESIA. (pp. 318P - 318P). OXFORD UNIV PRESS

Self, R; Mackie, IJ; Williams, AM; Jenkins, AMC; Mythen, MG; (2004) Activated thrombelastograph reaction (r) time is contact factor dependent and prolonged by DX-88, a novel kallikrein inhibitor, in cardiopulmonary bypass. In: (pp. A270-).

Shah, JS; Mehta, AB; Hughes, D; (2004) Arrhythmia in Anderson-Fabry Disease. Presented at: UNSPECIFIED.

Shah, JS; Thaman, R; Hughes, D; Murphy, R; Lee, P; Mehta, A; McKenna, WJ; (2004) The natural history of left ventricular systolic function in Anderson Fabry's disease (AFD). In: HEART. (pp. A59 - A59). B M J PUBLISHING GROUP

Sharp, T; Munoz, F; Bourboulia, D; Presneau, N; Darai, E; Wang, HW; Cannon, M; ... Boshoff, C; + view all (2004) LIMD1, a tumor suppressor at 3p21.3, binds pRb and represses E2F-driven transcription. Proceedings of the National Academy of Sciences of the United States of America , 10 pp. 16531-16536. 10.1073/pnas.0407123101.

Sharp, TV; Munoz, F; Bourboulia, D; Presneau, N; Darai, E; Wang, HW; Cannon, M; ... Boshoff, C; + view all (2004) LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proceedings of the National Academy of Sciences of the United States of America , 101 (47) pp. 16531-16536. 10.1073/pnas.0407123101.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPLANTATION , 34 (4) pp. 367-368.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; (2004) Scoring for HLA matching? A clinical test of HistoCheck. BONE MARROW TRANSPL , 34 (4) 367 - 368. 10.1038/sj.bmt.1704586.

Shaw, BE; Barber, LD; Madrigal, JA; Cleaver, S; Marsh, SGE; Elsner, HA; Blasczyk, R; (2004) Scoring for HLA matching? A clinical test of HistoCheck (multiple letters) [1]. Bone Marrow Transplantation , 34 (4) pp. 367-369. 10.1038/sj.bmt.1704586.

Shaw, BE; Maldonado, H; Madrigal, JA; Smith, C; Petronzelli, F; Mayor, NP; Potter, MN; ... Marsh, SGE; + view all (2004) Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation. Tissue Antigens , 63 (5) pp. 401-411. 10.1111/j.0001-2815.2004.00218.x.

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, JA; (2004) Increased disease relapse in HLA-DPB1 matched recipients of unrelated donor transplants is not confined to pairs matched for the other five HLA loci. In: BLOOD. (pp. 236A - 237A). AMER SOC HEMATOLOGY

Shaw, BE; Marsh, SGE; Mayor, NP; Madrigal, JA; (2004) Matching status at amino acid positions 57 and 65 of the HLA-DPB1 beta chain determines outcome in recipients of unrelated donor haematopoietic stem cell transplants. In: BLOOD. (pp. 236A - 236A). AMER SOC HEMATOLOGY

Shimuta, T; Nakano, K; Yamaguchi, Y; Ozaki, S; Fujimitsu, K; Matsunaga, C; Noguchi, K; ... Katayama, T; + view all (2004) Novel heat shock protein HspQ stimulates the degradation of mutant DnaA protein in Escherichia coli. GENES TO CELLS , 9 (12) pp. 1151-1166. 10.1111/j.1365-2443.2004.00800.x.

Short, S; (2004) UNSPECIFIED In: (Proceedings) ESTRO 23, Amsterdam.

Short, SC; Suovuori, A; Cook, G; Vivian, G; Harmer, C; (2004) A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer. Clinical Oncology , 16 (8) pp. 569-574.

Short, SM; Makris, A; Jones, RG; Novell, R; Harrison, M; (2004) Low dose continuous hyperfractionated accelerated radiation therapy (CHART) as preoperative treatment for rectal carcinoma. British Journal of Cancer , 91 S38-S38.

Sibtain, A; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2004) Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma. Clinical Oncology , 16 (1) pp. 58-62.

Sinclair, PB; Sorour, A; Martineau, M; Harrison, CJ; Mitchell, WA; O'Neill, E; Foroni, L; (2004) A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: Identification and analysis of a candidate tumor suppressor gene. CANCER RESEARCH , 64 (12) pp. 4089-4098. 10.1158/0008-5472.CAN-03-1871.

Sky, NRJJ; (2004) Cost issues behind government health reforms. UNSPECIFIED

Slee, EA; O'Connor, DJ; Lu, X; (2004) To die or not to die: how does p53 decide? Oncogene , 23 (16) pp. 2809-2818.

Soares, MVD; Plunkett, FJ; Verbeke, CS; Cook, JE; Faint, JM; Belaramani, LL; Fletcher, JM; ... Akbar, AN; + view all (2004) Integration of apoptosis and telomere erosion in virus-specific CD8(+) T cells from blood and tonsils during primary infection. BLOOD , 103 (1) 162 - 167. 10.1182/blood-2003-06-1791.

Spicer, J; Smith, P; Maclennan, K; Hoskin, P; Hancock, B; Linch, D; Pettengell, R; (2004) Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma. British Journal of Cancer , 90 (6) pp. 1151-1155. 10.1038/sj.bjc.6601675.

Springfield, C; Fielding, AK; Peng, K-W; Galanis, E; Russell, SJ; Cattaneo, R; (2004) Measles virus: improving natural oncolytic properties by genetic engineering. In: Horvarth, J and Sinkovics, J, (eds.) Viruses therapy of human cancers. Marcel Dekker Inc.: New York.

Stainsby, D; Cohen, H; Jones, H; (2004) The 2003 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Stainsby, D; Cohen, H; Jones, H; Beatty, C; Williamson, LM; (2004) Transfusion related lung injury: a major cause of transfusion associated mortality and morbidity. In: (Proceedings) British society for haematology annual scientific meeting.

Steele, AJ; Casanova, AA; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Jones, DT; Wickremasinghe, RG; (2004) The sesquiterpene lactone parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukemia cells. In: (pp. 949a-949b).

Stewart, G; Lee, SM; (2004) Poor performance status patients and the TOPICAL Trial. Lung Cancer in Practice , 1 (3) pp. 1-3.

Stewart, M; Daniell, K; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; ... Lee, M; + view all (2004) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral analogs of duocarmycin SA. In: (pp. U29-U29).

Strauss, SJ; McTiernan, A; Whelan, JS; (2004) Late relapse of osteosarcoma: Implications for follow-up and screening. PEDIATR BLOOD CANCER , 43 (6) 692 - 697. 10.1002/pbc.20154.

Streck, CJ; Zhang, Y; Miyamoto, R; Zhou, J; Ng, CYC; Nathwani, AC; Davidoff, AM; (2004) Restriction of neuroblastoma angiogenesis and growth by interferon-α/β. Surgery , 136 (2) pp. 183-189. 10.1016/j.surg.2004.04.014.

Streck, CJ; Zhou, JF; Ng, CY; Zhang, YB; Nathwani, AC; Davidoff, AM; (2004) Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , 199 (1) 78 - 86.

Sunder-Plassmann, G; Dehout, F; Schwarting, A; de Lorenzo, AG; Ricci, R; Kampmann, C; Beck, M; ... Widmer, U; + view all (2004) Uncontrolled hypertension in Fabry disease. American Journal of Hypertension , 17 (5) 475-.

Swanton, C; Johnston, S; (2004) New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, France. IDrugs , 7 (4) pp. 306-311.

T

T M Litchfield, G; S, S; R, F; M, S; S, P; K, ; (2004) UNSPECIFIED In: (Proceedings) Society for Neuroscience 34th Annual Meeting.

Taghian, A; Jagsi, R; Makris, A; Goldberg, S; Ceilley, E; Grignon, L; Powell, S; (2004) Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. International Journal of Radiation Oncology Biology Physics , 60 (3) pp. 706-714.

Taher, A; Aoun, E; Sharara, AI; Mourad, F; Gharzuddine, W; Koussa, S; Inati, A; ... Hoffbrand, AV; + view all (2004) Five-year trial of deferiprone chelation therapy in thalassaemia major patients. ACTA HAEMATOL-BASEL , 112 (4) 179 - 183. 10.1159/000081268.

Takamiya, K; Kostourou, V; Adams, S; Jadeja, S; Chalepakis, G; Scambler, PJ; Huganir, RL; (2004) A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1. NAT GENET , 36 (2) 172 - 177. 10.1038/ng1292.

Taylor, CM; Chua, C; Howie, AJ; Risdon, RA; (2004) Clinico-pathological findings in haemolytic uraemic syndrome not associated with diarrhoea. Pediatric Nephrology , 19 pp. 419-425.

Thomas, R; Godward, S; Makris, A; Bloomfield, D; Moody, AM; Williams, M; (2004) Giving patients a choice improves quality of life: A multi- centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole. Clinical Oncology , 16 (7) pp. 485-491.

Thomas, RM; Schmedt, C; Novelli, M; Choi, BK; Skok, J; Tarakhovsky, A; Roes, J; (2004) C-terminal Src kinase controls acute inflammation and granulocyte adhesion. IMMUNITY , 20 (2) 181 - 191.

Thomas, RM; Schmedt, C; Novelli, MR; Choi, BK; Skok, J; Tarakhovsky, A; Roe, J; (2004) Terminal SRC kinase controls acute inflammation and granulocyte adhesion. Immunity , 20 (2) pp. 181-191. 10.1016/S1074-7613(04)00023-8.

Tikhe, JG; Webber, SE; Hostomsky, Z; Maegley, KA; Ekkers, A; Li, JK; Yu, XH; ... Newell, DR; + view all (2004) Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. J MED CHEM , 47 (22) 5467 - 5481. 10.1021/jm030513r.

Tipping, AJ; Melo, JV; (2004) Comparative gene expression profile of p185(Bcr-Abl) versus p210(Bcr-Abl) expressing cells. LEUKEMIA RES , 28 (3) 219 - 220. 10.1016/j.leukres.2003.07.004.

Tipping, AJ; Vulliamy, TJ; Morgan, NV; Dokal, I; (2004) Molecular diagnosis of Fanconi anemia and dyskeratosis congenita. Methods Mol Med , 91 pp. 3-17.

Turner, NC; Ledermann, JA; (2004) First -line medical intervention for the treatment of epithelial ovarian cancer. In: Kehoe, S and Gore, M and Miles, A, (eds.) The Effective Management of Ovarian Cancer. (pp. 83-98). Aesculapius Medical Press: London.

Twelves, C; Gokul, S; Jones, RH; Boddy, A; Macham, M; Fishwick, K; Wheaton, J; ... Calvert, AH; + view all (2004) Phase I study to evaluate the safety, tolerability and pharmacokinetics of OSI-211 (Liposomal Lurtotecan) in combination with Carboplatin. ANN ONCOL , 15 105 - 105.

U

Urbaniak, MD; Bingham, JP; Hartley, JA; Woolfson, DN; Caddick, S; (2004) Improved Stability of Nitrogen-Mustard Derivatives Using apo-Neocarzinostatin. Journal of Medicinal Chemistry , 47 pp. 4710-4715.

V

Van Zuylen, L; Bridgewater, J; Sparreboom, A; Eskens, FALM; De Bruijn, P; Sklenar, I; Planting, AST; ... Verweij, J; + view all (2004) Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/Leucovorin in Metastatic Colorectal Cancer. Clinical Cancer Research , 10 (6) pp. 1949-1955. 10.1158/1078-0432.CCR-02-0995.

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: Attention to detail. CELL , 118 (3) pp. 274-276. 10.1016/j.cell.2004.07.018.

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: attention to detail. Cell , 118 (3) pp. 375-387.

Vassileva, VT; (2004) Release profile characterization of a novel Implantable paclitaxel loaded lipid polymer system in CD-1 mice. In: (Proceedings) American Association of Pharmaceutical Scientists Annual Meeting and Exposition.

Venables, K; Miles, EA; Aird, EGA; Hoskin, PJ; (2004) The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial. Radiotherapy and Oncology , 71 (3) pp. 303-310.

Venables, K; Miles, EA; Deighton, A; Aird, EGA; Hoskin, PJ; (2004) Irradiation of the heart during tangential breast treatment: a study within the START trial. British Journal of Radiology , 77 (914) pp. 137-142.

Vig, S; Sleight, S; Chitolie, A; Bevan, DH; Thompson, MM; Dormandy, J; Halliday, A; (2004) Prevalence of thrombophilia in patients with coronary artery and peripheral vascular disease. In: BRITISH JOURNAL OF SURGERY. (pp. 1234 - 1234). JOHN WILEY & SONS LTD

Vineis, P.; Alavanja, M.; Buffler, P.; Fontham, E.; Franceschi, S.; Gao, Y.T.; Gupta, P.C.; ... Doll, R.; + view all (2004) Tobacco and cancer: recent epidemiological evidence. CancerSpectrum Knowledge Environment , 96 (2) pp. 99-106. 10.1093/jnci/djh014.

Violet, JA; Francis, R; Buscombe, JR; Croasdale, J; Parker, S; Amlot, P; Green, AJ; ... Begent, RH; + view all (2004) A dose-escalation-study evaluating the toxicity and therapeutic efficacy of I-131 labelled chimeric antibody CHT-25 in patients with IL-2 expressing lymphomas. Preliminary results. BRITISH JOURNAL OF CANCER , 91 S59 - S59.

Virchis, A; Koh, M; Rankin, P; Mehta, A; Potter, M; Hoffbrand, AV; Prentice, HG; (2004) Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes. BRITISH JOURNAL OF HAEMATOLOGY , 124 (1) pp. 26-32. 10.1046/j.1365-2141.2003.04728.x.

van Zuylen, L; Bridgewater, J; Sparreboom, A; Eskens, FALM; de Bruijn, P; Sklenar, I; Planting, AST; ... Verweij, J; + view all (2004) Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. CLIN CANCER RES , 10 (6) 1949 - 1955.

W

Wald, N; Rodeck, C; Rudnicka, A; Hackshaw, A; (2004) Nuchal translucency and gestational age. Prenatal Diagnosis , 24 pp. 150-153.

Wald, NJ; Rodeck, CR; Ruldnicka, AR; Hackshaw, AK; (2004) Nuchal translucency and gestational age - Response to Nicolaides. PRENATAL DIAG , 24 (10) 834 - 835. 10.1002/pd.1046.

Wallace, E; Hinds, A; Campbell, H; Mackay, J; Cetnarskyj, R; Porteous, ME; (2004) A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. British Journal of Cancer , 91 (8) pp. 1575-1579.

Walsh, V; Gilkes, AF; Sweeney, M; Austin, SJ; Gale, RE; Mills, KI; (2004) Rapid and quantitative detection of mutations of the FLT3 gene in AML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 68 - 69). BLACKWELL PUBLISHING LTD

Walton, J; Lawson, K; Manoussaka, MS; Nathwani, A; Emory, V; Lydyard, PM; Porakishvili, N; (2004) Perforin expressing CD4+T cells respond to CMV antigens in CMV seropositive patients with B cell chronic lymphocytic leukaemia (B-CLL). In: BLOOD. (pp. 280B - 280B). AMER SOC HEMATOLOGY

Waterston, A; Thirlwell, C; Newsom-Davis, T; Powles, T; Nelson, M; Gazzard, B; Bower, M; (2004) Does highly active antiretroviral therapy (HAART) affect the incidence or outcome of invasive anal cancer? In: BRITISH JOURNAL OF CANCER. (pp. S13 - S13). NATURE PUBLISHING GROUP

Watts, MJ; Ings, SJ; Balsa, C; Penn, C; Leverett, D; Linch, DC; (2004) Successful customization of peripheral blood stem cell harvest volume and cell concentration during apheresis. In: BLOOD. (pp. 330B - 330B). AMER SOC HEMATOLOGY

Watts, MJ; Ings, SJ; Balsa, C; Penn, C; Linch, DC; (2004) Thermally induced catastrophic cryocyte breaks. In: BONE MARROW TRANSPLANTATION. (pp. S309 - S309). NATURE PUBLISHING GROUP

Whelan, J; (2004) Late Effects of Childhood Cancer. Lancet Oncology

Whelan, JS; McTiernan, A; (2004) for the London Bone and Soft Tissue Tumour Service. A prospective study of pre-operative chemotherapy with single agent ifosfamide for malignant fibrous histiocytoma of bone. Sarcoma , 8 pp. 77-82. Gold open access

Whelan, JS; McTiernan, AM; Strauss, SJ; (2004) Single centre experience of a new intensive induction therapy for Ewing’s family of tumours using Holoxan in the VIDE regimen. Final results and conclusions. In:

Whelan, JS; Morland, B; (2004) Bone Tumours. In: Pinkerton, CR and Plowman, P, (eds.) Paediatric Oncology. Clinical Practice and Controversies. : London.

Whitelegg, A; Barber, LD; (2004) The structural basis of T-cell allorecognition. TISSUE ANTIGENS , 63 (2) pp. 101-108.

Williams, KE; Gardiner, C; Mackie, IJ; Machin, SJ; Cohen, H; (2004) Patient self-testing of INR is a safe and acceptable alternative to laboratory-based testing. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 56 - 57). BLACKWELL PUBLISHING LTD

Williams, KE; Gardiner, C; Mackie, IJ; machin, SJ; Cohen, H; (2004) Patient self-testing of the INR is a safe and acceptable alternative to laboratory-based testing. In: (Proceedings) British society for haematology annual scientific meeting.

Wilson, C; Nikitenko, LL; Sargent, IL; Rees, MCP; (2004) Adrenomedullin: multiple functions in human pregnancy. Angiogenesis , 7 (3) pp. 203-212. 10.1007/s10456-004-4183-5.

Wohrer, S; Isaacson, PG; Raderer, M; (2004) Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Annals of Hematology , 83 (10) p. 666.

Y

Yamano, H; Gannon, J; Mahbubani, H; Hunt, T; (2004) Cell cycle-regulated recognition of the destruction box of cyclin B by the APC/C in Xenopus egg extracts. Mol. Cell , 13 (1) pp. 137-147.

Yamano, H; Kominami, K; Harrison, C; Kitamura, K; Katayama, S; Dhut, S; Hunt, T; (2004) Requirement of the SCFPop1/Pop2 Ubiquitin Ligase for Degradation of the Fission Yeast S Phase Cyclin Cig2. J. Biol. Chem. , 279 (18) pp. 18974-18980. Gold open access

Yarranton, H; Lawrie, AS; Mackie, IJ; Pinkoski, L; Corash, L; Machin, SJ; (2004) Amotosalen hydrochloride (S-59) and UVA light treatment of cryosupernatant has no clinically significant effect on haemostatic proteins and appears suitable for plasma exchange in thrombotic thrombocytopenic purpura. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 34 - 34). BLACKWELL PUBLISHING LTD

Yarranton, H; Lawrie, AS; Purdy, G; Mackie, IJ; Machin, SJ; (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. TRANSFUSION MED , 14 (1) 39 - 44.

Ye, HT; Chuang, SS; Dogan, A; Isaacson, PG; Du, MQ; (2004) t(1;14) and t(11;18) in the differential diagnosis of Waldenstrom's macroglobulinemia. MODERN PATHOLOGY , 17 (9) pp. 1150-1154. 10.1038/modpathol.3800164.

Yung, L; Cunningham, D; Hancock, B; Smith, P; Maclennan, K; Linch, D; McMillan, A; (2004) Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI). Br J Cancer , 91 (4) pp. 695-698. 10.1038/sj.bjc.6602031.

Yung, L; Smith, P; Hancock, BW; Hoskin, P; Gilson, D; Vernon, C; Linch, DC; (2004) Long term outcome in adolescents with Hodgkin's lymphoma: Poor results using regimens designed for adults. LEUKEMIA LYMPHOMA , 45 (8) 1579 - 1585. 10.1080/1042819042000209404.

Z

Zal, B; am, K; Juan, A; Gavin, A; Julius, X; Qingbo, C; Della, W; ... Baboonian, C; + view all (2004) Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. CIRCULATION , 109 (10) pp. 1230-1235.

This list was generated on Sun Apr 15 02:50:19 2018 BST.